{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:20:38Z","timestamp":1782285638975,"version":"3.54.5"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Royal Danish Library, Aarhus University Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s40264-023-01298-0","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T19:03:04Z","timestamp":1683054184000},"page":"533-543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of Lifestyle and Socioeconomic Position on the Association Between Non-steroidal Anti-inflammatory Drug Use and Major Adverse Cardiovascular Events: A Case-Crossover Study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8626-2372","authenticated-orcid":false,"given":"Kasper","family":"Bonnesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Ehrenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Stjerne","family":"Gr\u00f8nkj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Hallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Lee","family":"Lash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"1298_CR1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/eurheartj\/ehv505","volume":"37","author":"M Schmidt","year":"2016","unstructured":"Schmidt M, Lamberts M, Olsen AM, et al. Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology. Eur Heart J. 2016;37:1015\u201323. https:\/\/doi.org\/10.1093\/eurheartj\/ehv505.","journal-title":"Eur Heart J"},{"key":"1298_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa073","author":"M Schmidt","year":"2020","unstructured":"Schmidt M, Potteg\u00e5rd A. Prescriber responsibility, predictors for initiation, and 20-year trends in use of non-aspirin non-steroidal anti-inflammatory drugs in patients with cardiovascular contraindications: a nationwide cohort study. Eur Heart J Cardiovasc Pharmacother. 2020. https:\/\/doi.org\/10.1093\/ehjcvp\/pvaa073.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"1298_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5571","author":"K Bonnesen","year":"2022","unstructured":"Bonnesen K, Ehrenstein V, Gr\u00f8nkjaer MS, et al. Impact of lifestyle and socioeconomic position on use of non-steroidal anti-inflammatory drugs: a population-based cohort study. Pharmacoepidemiol Drug Saf. 2022. https:\/\/doi.org\/10.1002\/pds.5571.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1298_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/clep.S179083","volume":"11","author":"M Schmidt","year":"2019","unstructured":"Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563\u201391. https:\/\/doi.org\/10.2147\/clep.S179083.","journal-title":"Clin Epidemiol"},{"key":"1298_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, S\u00f8rensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541\u20139. https:\/\/doi.org\/10.1007\/s10654-014-9930-3.","journal-title":"Eur J Epidemiol"},{"key":"1298_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/joim.12186","volume":"275","author":"J Hallas","year":"2014","unstructured":"Hallas J, Potteg\u00e5rd A. Use of self-controlled designs in pharmacoepidemiology. J Intern Med. 2014;275:581\u20139. https:\/\/doi.org\/10.1111\/joim.12186.","journal-title":"J Intern Med"},{"key":"1298_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/1403494820966534","author":"AI Christensen","year":"2020","unstructured":"Christensen AI, Lau CJ, Kristensen PL, et al. The Danish National Health Survey: study design, response rate and respondent characteristics in 2010, 2013 and 2017. Scand J Public Health. 2020. https:\/\/doi.org\/10.1177\/1403494820966534.","journal-title":"Scand J Public Health"},{"key":"1298_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/clep.S59156","volume":"6","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Hallas J, Friis S. Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999\u20132012. Clin Epidemiol. 2014;6:155\u201368. https:\/\/doi.org\/10.2147\/clep.S59156.","journal-title":"Clin Epidemiol"},{"key":"1298_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0895-4356(94)90023-x","volume":"47","author":"TP van Staa","year":"1994","unstructured":"van Staa TP, Abenhaim L, Leufkens H. A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies. J Clin Epidemiol. 1994;47:183\u20139. https:\/\/doi.org\/10.1016\/0895-4356(94)90023-x.","journal-title":"J Clin Epidemiol"},{"issue":"107\u2013113","key":"1298_CR10","doi-asserted-by":"publisher","first-page":"20150604","DOI":"10.1016\/j.jclinepi.2015.05.026","volume":"69","author":"SJ Sinnott","year":"2016","unstructured":"Sinnott SJ, Polinski JM, Byrne S, et al. Measuring drug exposure: concordance between defined daily dose and days\u2019 supply depended on drug class. J Clin Epidemiol. 2016;69(107\u2013113):20150604. https:\/\/doi.org\/10.1016\/j.jclinepi.2015.05.026.","journal-title":"J Clin Epidemiol"},{"key":"1298_CR11","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/ije\/dyw213","volume":"46","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Schmidt SAJ, Wallach-Kildemoes H, et al. Data resource profile: the Danish National Prescription Registry. Int J Epidemiol. 2017;46:798\u2013798f. https:\/\/doi.org\/10.1093\/ije\/dyw213.","journal-title":"Int J Epidemiol"},{"issue":"769\u2013779","key":"1298_CR12","doi-asserted-by":"publisher","first-page":"20130530","DOI":"10.1016\/s0140-6736(13)60900-9","volume":"382","author":"N Bhala","year":"2013","unstructured":"Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (London, England). 2013;382(769\u2013779):20130530. https:\/\/doi.org\/10.1016\/s0140-6736(13)60900-9.","journal-title":"Lancet (London, England)"},{"key":"1298_CR13","doi-asserted-by":"publisher","first-page":"c7086","DOI":"10.1136\/bmj.c7086","volume":"342","author":"S Trelle","year":"2011","unstructured":"Trelle S, Reichenbach S, Wandel S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ (Clin Res Ed). 2011;342:c7086. https:\/\/doi.org\/10.1136\/bmj.c7086.","journal-title":"BMJ (Clin Res Ed)"},{"key":"1298_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/clep.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SA, Sandegaard JL, et al. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390. https:\/\/doi.org\/10.2147\/clep.S91125.","journal-title":"Clin Epidemiol"},{"key":"1298_CR15","doi-asserted-by":"publisher","first-page":"e012832","DOI":"10.1136\/bmjopen-2016-012832","volume":"6","author":"J Sundb\u00f8ll","year":"2016","unstructured":"Sundb\u00f8ll J, Adelborg K, Munch T, et al. Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open. 2016;6:e012832. https:\/\/doi.org\/10.1136\/bmjopen-2016-012832.","journal-title":"BMJ Open"},{"key":"1298_CR16","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/s0895-4356(02)00391-8","volume":"55","author":"SP Johnsen","year":"2002","unstructured":"Johnsen SP, Overvad K, S\u00f8rensen HT, et al. Predictive value of stroke and transient ischemic attack discharge diagnoses in the Danish National Registry of Patients. J Clin Epidemiol. 2002;55:602\u20137. https:\/\/doi.org\/10.1016\/s0895-4356(02)00391-8.","journal-title":"J Clin Epidemiol"},{"key":"1298_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1403494811405098","volume":"39","author":"M Baadsgaard","year":"2011","unstructured":"Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39:103\u20135. https:\/\/doi.org\/10.1177\/1403494811405098.","journal-title":"Scand J Public Health"},{"key":"1298_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1403494811408483","volume":"39","author":"F Petersson","year":"2011","unstructured":"Petersson F, Baadsgaard M, Thygesen LC. Danish registers on personal labour market affiliation. Scand J Public Health. 2011;39:95\u20138. https:\/\/doi.org\/10.1177\/1403494811408483.","journal-title":"Scand J Public Health"},{"key":"1298_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676\u201382. https:\/\/doi.org\/10.1093\/aje\/kwq433.","journal-title":"Am J Epidemiol"},{"key":"1298_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130\u20139. https:\/\/doi.org\/10.1097\/01.mlr.0000182534.19832.83.","journal-title":"Med Care"},{"key":"1298_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/oxfordjournals.aje.a115853","volume":"133","author":"M Maclure","year":"1991","unstructured":"Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133:144\u201353. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a115853.","journal-title":"Am J Epidemiol"},{"key":"1298_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12874-021-01408-5","volume":"21","author":"K Kubota","year":"2021","unstructured":"Kubota K, Kelly TL, Sato T, et al. A novel weighting method to remove bias from within-subject exposure dependency in case-crossover studies. BMC Med Res Methodol. 2021;21:214. https:\/\/doi.org\/10.1186\/s12874-021-01408-5.","journal-title":"BMC Med Res Methodol"},{"key":"1298_CR23","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/aje\/kwab110","volume":"190","author":"J Hallas","year":"2021","unstructured":"Hallas J, Whitaker H, Delaney JA, et al. The use of active comparators in self-controlled designs. Am J Epidemiol. 2021;190:2181\u20137. https:\/\/doi.org\/10.1093\/aje\/kwab110.","journal-title":"Am J Epidemiol"},{"issue":"422\u2013427","key":"1298_CR24","doi-asserted-by":"publisher","first-page":"20091031","DOI":"10.1016\/j.jclinepi.2009.07.001","volume":"63","author":"H Gardarsdottir","year":"2010","unstructured":"Gardarsdottir H, Souverein PC, Egberts TC, et al. Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length. J Clin Epidemiol. 2010;63(422\u2013427):20091031. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.07.001.","journal-title":"J Clin Epidemiol"},{"key":"1298_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","volume":"3","author":"SS Khan","year":"2018","unstructured":"Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018;3:280\u20137. https:\/\/doi.org\/10.1001\/jamacardio.2018.0022.","journal-title":"JAMA Cardiol"},{"issue":"1083\u20131096","key":"1298_CR26","doi-asserted-by":"publisher","first-page":"20090318","DOI":"10.1016\/s0140-6736(09)60318-4","volume":"373","author":"G Whitlock","year":"2009","unstructured":"Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (London, England). 2009;373(1083\u20131096):20090318. https:\/\/doi.org\/10.1016\/s0140-6736(09)60318-4.","journal-title":"Lancet (London, England)"},{"key":"1298_CR27","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/s0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case\u2013control study. Lancet (London, England). 2004;364:937\u201352. https:\/\/doi.org\/10.1016\/s0140-6736(04)17018-9.","journal-title":"Lancet (London, England)"},{"key":"1298_CR28","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1136\/bmj.316.7137.1043","volume":"316","author":"E Prescott","year":"1998","unstructured":"Prescott E, Hippe M, Schnohr P, et al. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ (Clin Res Ed). 1998;316:1043\u20137. https:\/\/doi.org\/10.1136\/bmj.316.7137.1043.","journal-title":"BMJ (Clin Res Ed)"},{"issue":"1160\u20131166","key":"1298_CR29","doi-asserted-by":"publisher","first-page":"20110315","DOI":"10.1016\/j.hrthm.2011.03.038","volume":"8","author":"AM Chamberlain","year":"2011","unstructured":"Chamberlain AM, Agarwal SK, Folsom AR, et al. Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study. Heart Rhythm. 2011;8(1160\u20131166):20110315. https:\/\/doi.org\/10.1016\/j.hrthm.2011.03.038.","journal-title":"Heart Rhythm"},{"issue":"h1551","key":"1298_CR30","doi-asserted-by":"publisher","first-page":"20150420","DOI":"10.1136\/bmj.h1551","volume":"350","author":"U Mons","year":"2015","unstructured":"Mons U, M\u00fcezzinler A, Gellert C, et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ (Clin Res Ed). 2015;350(h1551):20150420. https:\/\/doi.org\/10.1136\/bmj.h1551.","journal-title":"BMJ (Clin Res Ed)"},{"key":"1298_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jama.289.5.579","volume":"289","author":"K Reynolds","year":"2003","unstructured":"Reynolds K, Lewis B, Nolen JD, et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289:579\u201388. https:\/\/doi.org\/10.1001\/jama.289.5.579.","journal-title":"JAMA"},{"key":"1298_CR32","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1001\/archinte.166.22.2437","volume":"166","author":"A Di Castelnuovo","year":"2006","unstructured":"Di Castelnuovo A, Costanzo S, Bagnardi V, et al. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006;166:2437\u201345. https:\/\/doi.org\/10.1001\/archinte.166.22.2437.","journal-title":"Arch Intern Med"},{"key":"1298_CR33","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1046\/j.1360-0443.2000.951015056.x","volume":"95","author":"G Corrao","year":"2000","unstructured":"Corrao G, Rubbiati L, Bagnardi V, et al. Alcohol and coronary heart disease: a meta-analysis. Addiction (Abingdon, England). 2000;95:1505\u201323. https:\/\/doi.org\/10.1046\/j.1360-0443.2000.951015056.x.","journal-title":"Addiction (Abingdon, England)"},{"key":"1298_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/jama.1996.03540030039029","volume":"276","author":"SN Blair","year":"1996","unstructured":"Blair SN, Kampert JB, Kohl HW 3rd, et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA. 1996;276:205\u201310.","journal-title":"JAMA"},{"key":"1298_CR35","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/nejm198603063141003","volume":"314","author":"RS Paffenbarger Jr","year":"1986","unstructured":"Paffenbarger RS Jr, Hyde RT, Wing AL, et al. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med. 1986;314:605\u201313. https:\/\/doi.org\/10.1056\/nejm198603063141003.","journal-title":"N Engl J Med"},{"issue":"807\u2013814","key":"1298_CR36","doi-asserted-by":"publisher","first-page":"20130914","DOI":"10.1007\/s10654-013-9847-2","volume":"28","author":"KN Kershaw","year":"2013","unstructured":"Kershaw KN, Droomers M, Robinson WR, et al. Quantifying the contributions of behavioral and biological risk factors to socioeconomic disparities in coronary heart disease incidence: the MORGEN study. Eur J Epidemiol. 2013;28(807\u2013814):20130914. https:\/\/doi.org\/10.1007\/s10654-013-9847-2.","journal-title":"Eur J Epidemiol"},{"issue":"5190\u20135195","key":"1298_CR37","doi-asserted-by":"publisher","first-page":"20130729","DOI":"10.1016\/j.ijcard.2013.07.188","volume":"168","author":"C M\u00e9jean","year":"2013","unstructured":"M\u00e9jean C, Droomers M, van der Schouw YT, et al. The contribution of diet and lifestyle to socioeconomic inequalities in cardiovascular morbidity and mortality. Int J Cardiol. 2013;168(5190\u20135195):20130729. https:\/\/doi.org\/10.1016\/j.ijcard.2013.07.188.","journal-title":"Int J Cardiol"},{"issue":"2014\u20132022","key":"1298_CR38","doi-asserted-by":"publisher","first-page":"20091012","DOI":"10.1136\/hrt.2009.182436","volume":"95","author":"A Rosengren","year":"2009","unstructured":"Rosengren A, Subramanian SV, Islam S, et al. Education and risk for acute myocardial infarction in 52 high, middle and low-income countries: INTERHEART case-control study. Heart (Br Card Soc). 2009;95(2014\u20132022):20091012. https:\/\/doi.org\/10.1136\/hrt.2009.182436.","journal-title":"Heart (Br Card Soc)"},{"issue":"e006408","key":"1298_CR39","doi-asserted-by":"publisher","first-page":"20150317","DOI":"10.1136\/bmjopen-2014-006408","volume":"5","author":"M Woodward","year":"2015","unstructured":"Woodward M, Peters SA, Batty GD, et al. Socioeconomic status in relation to cardiovascular disease and cause-specific mortality: a comparison of Asian and Australasian populations in a pooled analysis. BMJ Open. 2015;5(e006408):20150317. https:\/\/doi.org\/10.1136\/bmjopen-2014-006408.","journal-title":"BMJ Open"},{"key":"1298_CR40","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/ije\/30.5.1119","volume":"30","author":"L Kilander","year":"2001","unstructured":"Kilander L, Berglund L, Boberg M, et al. Education, lifestyle factors and mortality from cardiovascular disease and cancer. A 25-year follow-up of Swedish 50-year-old men. Int J Epidemiol. 2001;30:1119\u201326. https:\/\/doi.org\/10.1093\/ije\/30.5.1119.","journal-title":"Int J Epidemiol"},{"key":"1298_CR41","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/2013.jamainternmed.447","volume":"172","author":"ME Dupre","year":"2012","unstructured":"Dupre ME, George LK, Liu G, et al. The cumulative effect of unemployment on risks for acute myocardial infarction. Arch Intern Med. 2012;172:1731\u20137. https:\/\/doi.org\/10.1001\/2013.jamainternmed.447.","journal-title":"Arch Intern Med"},{"issue":"707\u2013716","key":"1298_CR42","doi-asserted-by":"publisher","first-page":"20141111","DOI":"10.1007\/s00420-014-0997-7","volume":"88","author":"P Meneton","year":"2015","unstructured":"Meneton P, Kesse-Guyot E, M\u00e9jean C, et al. Unemployment is associated with high cardiovascular event rate and increased all-cause mortality in middle-aged socially privileged individuals. Int Arch Occup Environ Health. 2015;88(707\u2013716):20141111. https:\/\/doi.org\/10.1007\/s00420-014-0997-7.","journal-title":"Int Arch Occup Environ Health"},{"issue":"1937\u20131948","key":"1298_CR43","doi-asserted-by":"publisher","first-page":"20180619","DOI":"10.1136\/heartjnl-2018-313005","volume":"104","author":"CW Wong","year":"2018","unstructured":"Wong CW, Kwok CS, Narain A, et al. Marital status and risk of cardiovascular diseases: a systematic review and meta-analysis. Heart (Br Card Soc). 2018;104(1937\u20131948):20180619. https:\/\/doi.org\/10.1136\/heartjnl-2018-313005.","journal-title":"Heart (Br Card Soc)"},{"issue":"123\u2013129","key":"1298_CR44","doi-asserted-by":"publisher","first-page":"20120114","DOI":"10.2188\/jea.je20100175","volume":"22","author":"B Hu","year":"2012","unstructured":"Hu B, Li W, Wang X, et al. Marital status, education, and risk of acute myocardial infarction in Mainland China: the INTER-HEART study. J Epidemiol. 2012;22(123\u2013129):20120114. https:\/\/doi.org\/10.2188\/jea.je20100175.","journal-title":"J Epidemiol"},{"key":"1298_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00109-007-0162-9","volume":"85","author":"J Metzner","year":"2007","unstructured":"Metzner J, Popp L, Marian C, et al. The effects of COX-2 selective and non-selective NSAIDs on the initiation and progression of atherosclerosis in ApoE\u2212\/\u2212 mice. J Mol Med (Berlin, Germany). 2007;85:623\u201333. https:\/\/doi.org\/10.1007\/s00109-007-0162-9.","journal-title":"J Mol Med (Berlin, Germany)"},{"issue":"490\u2013496","key":"1298_CR46","doi-asserted-by":"publisher","first-page":"20050214","DOI":"10.1001\/archinte.165.5.IOI50013","volume":"165","author":"TJ Aw","year":"2005","unstructured":"Aw TJ, Haas SJ, Liew D, et al. Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure. Arch Intern Med. 2005;165(490\u2013496):20050214. https:\/\/doi.org\/10.1001\/archinte.165.5.IOI50013.","journal-title":"Arch Intern Med"},{"key":"1298_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2021.06.014","author":"K Bonnesen","year":"2021","unstructured":"Bonnesen K, Schmidt M. Re-categorization of non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) according to clinical relevance: abandoning the \u2018traditional NSAID\u2019 terminology. Can J Cardiol. 2021. https:\/\/doi.org\/10.1016\/j.cjca.2021.06.014.","journal-title":"Can J Cardiol"},{"key":"1298_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-med-011209-153129","volume":"61","author":"T Grosser","year":"2010","unstructured":"Grosser T, Yu Y, Fitzgerald GA. Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med. 2010;61:17\u201333. https:\/\/doi.org\/10.1146\/annurev-med-011209-153129.","journal-title":"Annu Rev Med"},{"issue":"55\u201373","key":"1298_CR49","doi-asserted-by":"publisher","first-page":"20180911","DOI":"10.1002\/jcph.1302","volume":"59","author":"LH Mart\u00edn Arias","year":"2019","unstructured":"Mart\u00edn Arias LH, Mart\u00edn Gonz\u00e1lez A, Sanz Fadrique R, et al. Cardiovascular risk of nonsteroidal anti-inflammatory drugs and classical and selective cyclooxygenase-2 inhibitors: a meta-analysis of observational studies. J Clin Pharmacol. 2019;59(55\u201373):20180911. https:\/\/doi.org\/10.1002\/jcph.1302.","journal-title":"J Clin Pharmacol"},{"key":"1298_CR50","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/pds.3437","volume":"22","author":"C Varas-Lorenzo","year":"2013","unstructured":"Varas-Lorenzo C, Riera-Guardia N, Calingaert B, et al. Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies. Pharmacepidemiol Drug Saf. 2013;22:559\u201370. https:\/\/doi.org\/10.1002\/pds.3437.","journal-title":"Pharmacepidemiol Drug Saf"},{"key":"1298_CR51","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/ije\/dyi060","volume":"34","author":"AM Jurek","year":"2005","unstructured":"Jurek AM, Greenland S, Maldonado G, et al. Proper interpretation of non-differential misclassification effects: expectations vs observations. Int J Epidemiol. 2005;34:680\u20137. https:\/\/doi.org\/10.1093\/ije\/dyi060.","journal-title":"Int J Epidemiol"},{"key":"1298_CR52","unstructured":"Tricykliske antidepressiva (TCA). https:\/\/pro.medicin.dk\/Laegemiddelgrupper\/Grupper\/243030. Accessed 4 Feb 2023."},{"issue":"383\u2013390","key":"1298_CR53","doi-asserted-by":"publisher","first-page":"20070920","DOI":"10.1096\/fj.07-8506com","volume":"22","author":"B Hinz","year":"2008","unstructured":"Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J. 2008;22(383\u2013390):20070920. https:\/\/doi.org\/10.1096\/fj.07-8506com.","journal-title":"FASEB J"},{"key":"1298_CR54","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1136\/annrheumdis-2014-206914","volume":"75","author":"E Roberts","year":"2016","unstructured":"Roberts E, Delgado Nunes V, Buckner S, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75:552\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206914.","journal-title":"Ann Rheum Dis"},{"key":"1298_CR55","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/eurheartj\/ehac059","volume":"43","author":"C Zeng","year":"2022","unstructured":"Zeng C, Rosenberg L, Li X, et al. Sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension. Eur Heart J. 2022;43:1743\u201355. https:\/\/doi.org\/10.1093\/eurheartj\/ehac059.","journal-title":"Eur Heart J"},{"issue":"416\u2013423","key":"1298_CR56","doi-asserted-by":"publisher","first-page":"20220207","DOI":"10.1161\/circulationaha.121.056015","volume":"145","author":"IM MacIntyre","year":"2022","unstructured":"MacIntyre IM, Turtle EJ, Farrah TE, et al. Regular acetaminophen use and blood pressure in people with hypertension: the PATH-BP trial. Circulation. 2022;145(416\u2013423):20220207. https:\/\/doi.org\/10.1161\/circulationaha.121.056015.","journal-title":"Circulation"},{"key":"1298_CR57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/sj.jhh.1000949","volume":"14","author":"WB Kannel","year":"2000","unstructured":"Kannel WB. Fifty years of Framingham Study contributions to understanding hypertension. J Hum Hypertens. 2000;14:83\u201390. https:\/\/doi.org\/10.1038\/sj.jhh.1000949.","journal-title":"J Hum Hypertens"},{"key":"1298_CR58","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459\u201372. https:\/\/doi.org\/10.1093\/eurheartj\/ehx144.","journal-title":"Eur Heart J"},{"key":"1298_CR59","first-page":"333","volume-title":"Modern epidemiology, chapter 15: precision and study size","author":"TL Lash","year":"2021","unstructured":"Lash TL, Vanderweele TJ, Haneuse S, et al. Modern epidemiology, chapter 15: precision and study size. 4th ed. Philadelphia: Wolters Kluwer; 2021. p. 333\u201364.","edition":"4"},{"key":"1298_CR60","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.2009.2017","volume":"303","author":"G Tomlinson","year":"2010","unstructured":"Tomlinson G, Detsky AS. Composite end points in randomized trials: there is no free lunch. JAMA. 2010;303:267\u20138. https:\/\/doi.org\/10.1001\/jama.2009.2017.","journal-title":"JAMA"},{"key":"1298_CR61","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/bmj.330.7491.594","volume":"330","author":"VM Montori","year":"2005","unstructured":"Montori VM, Permanyer-Miralda G, Ferreira-Gonz\u00e1lez I, et al. Validity of composite end points in clinical trials. BMJ (Clin Res Ed). 2005;330:594\u20136. https:\/\/doi.org\/10.1136\/bmj.330.7491.594.","journal-title":"BMJ (Clin Res Ed)"},{"key":"1298_CR62","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1001\/jama.289.19.2575","volume":"289","author":"MS Lauer","year":"2003","unstructured":"Lauer MS, Topol EJ. Clinical trials\u2013multiple treatments, multiple end points, and multiple lessons. JAMA. 2003;289:2575\u20137. https:\/\/doi.org\/10.1001\/jama.289.19.2575.","journal-title":"JAMA"},{"issue":"k3426","key":"1298_CR63","doi-asserted-by":"publisher","first-page":"20180904","DOI":"10.1136\/bmj.k3426","volume":"362","author":"M Schmidt","year":"2018","unstructured":"Schmidt M, S\u00f8rensen HT, Pedersen L. Diclofenac use and cardiovascular risks: series of nationwide cohort studies. BMJ (Clin Res Ed). 2018;362(k3426):20180904. https:\/\/doi.org\/10.1136\/bmj.k3426.","journal-title":"BMJ (Clin Res Ed)"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-023-01298-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-023-01298-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-023-01298-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T15:08:47Z","timestamp":1685113727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-023-01298-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1298"],"URL":"https:\/\/doi.org\/10.1007\/s40264-023-01298-0","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"20 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Royal Danish Library. The Department of Clinical Epidemiology, Aarhus University Hospital funded the research. The Department receives funding for other studies from companies in the form of research grants to and administered by Aarhus University. None of those studies have any relation to the present study. The Danish National Health Survey was funded by the Capital Region; Region Zealand; the South Denmark Region; the Central Denmark Region; the North Denmark Region; the Ministry of Health, and the National Institute of Public Health, University of Southern Denmark.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"TLL is a member of the Amgen Methods Council, for which he receives consulting fees and travel support. The remaining contributing authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Danish Data Protection Agency (record number: 2015-57-0002) via Aarhus University (record number: 2016-051-000001).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"According to the Danish legislation, informed consent is not required for studies based solely on registry data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data materials"}},{"value":"Codes are available upon reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"KB, JH, TLL, and MS designed the study. KB, LP, HTS, and MS collected the data. KB performed the analyses. KB, LP, VE, MSG, HTS, JH, TLL, and MS interpreted the data. KB developed the manuscript. LP, VE, MSG, HTS, JH, TLL, and MS critically revised the article\u2019s intellectual content. All authors approve the final version of the article to be published.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}